These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9247844)

  • 41. In vitro screening of plant extracts and phytopharmaceuticals: novel approaches for the elucidation of active compounds and their mechanisms.
    Gebhardt R
    Planta Med; 2000 Mar; 66(2):99-105. PubMed ID: 10763579
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of vegetal extracts as biological herbi- and pesticides for their use in Cuban agriculture.
    De Cupere F; Vandebroek I; Puentes M; Torres S; Van Damme P
    Meded Rijksuniv Gent Fak Landbouwkd Toegep Biol Wet; 2001; 66(2a):455-62. PubMed ID: 12425066
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quality specifications for peptide drugs: a regulatory-pharmaceutical approach.
    Vergote V; Burvenich C; Van de Wiele C; De Spiegeleer B
    J Pept Sci; 2009 Nov; 15(11):697-710. PubMed ID: 19750489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ethyl acetate extract of Chinese medicinal herb Sarcandra glabra induces growth inhibition on human leukemic HL-60 cells, associated with cell cycle arrest and up-regulation of pro-apoptotic Bax/Bcl-2 ratio.
    Li WY; Chiu LC; Lam WS; Wong WY; Chan YT; Ho YP; Wong EY; Wong YS; Ooi VE
    Oncol Rep; 2007 Feb; 17(2):425-31. PubMed ID: 17203183
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the anti-proliferative effect the extracts of Allamanda blanchetti and A. schottii on the growth of leukemic and endothelial cells.
    de F Navarro Schmidt D; Yunes RA; Schaab EH; Malheiros A; Cechinel Filho V; Franchi GC; Nowill AE; Cardoso AA; Yunes J
    J Pharm Pharm Sci; 2006; 9(2):200-8. PubMed ID: 16959189
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New perspectives for synergy research with the "omic"-technologies.
    Ulrich-Merzenich G; Panek D; Zeitler H; Wagner H; Vetter H
    Phytomedicine; 2009 Jun; 16(6-7):495-508. PubMed ID: 19428231
    [TBL] [Abstract][Full Text] [Related]  

  • 47. How and why should we standardize phytopharmaceutical drugs for clinical validation?
    Bonati A
    J Ethnopharmacol; 1991 Apr; 32(1-3):195-7. PubMed ID: 1881157
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quality assessment of herbal preparations as a precondition of pharmacological and clinical studies.
    Bauer R; Tittel G
    Phytomedicine; 1996 Jan; 2(3):193-8. PubMed ID: 23194615
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Determination of the inhibitory effect of a biologically active preparation on the reproduction of micro-organisms from the intestines of ruminants].
    Novák S; Blaho J; Edelman R
    Vet Med (Praha); 1987 Jun; 32(6):337-42. PubMed ID: 3113030
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Editorial guidelines for manuscripts on the pharmacology of plant extracts.
    Michel MC; König G; Mohr K; Simmet T
    Naunyn Schmiedebergs Arch Pharmacol; 2005 May; 371(5):349-50. PubMed ID: 16007459
    [No Abstract]   [Full Text] [Related]  

  • 51. [Proposals for the pharmacopoeia: tinctures and extracts].
    Carlassare M
    Boll Chim Farm; 1981 Jun; 120(6):351-68. PubMed ID: 7306398
    [No Abstract]   [Full Text] [Related]  

  • 52. [Extraction intensification in determining the extractive substances in plant raw material].
    Muravev IA; Pshukov IuG; Berezhnaia LS
    Farmatsiia; 1976; 25(4):16-20. PubMed ID: 1010044
    [No Abstract]   [Full Text] [Related]  

  • 53. Use of statistical tests of equivalence (bioequivalence tests) in plant pathology.
    Garrett KA
    Phytopathology; 1997 Apr; 87(4):372-4. PubMed ID: 18945114
    [No Abstract]   [Full Text] [Related]  

  • 54. Revised editorial guidelines for manuscripts on the pharmacology of plant extracts.
    Merfort I; Michel MC; Seifert R
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Aug; 390(8):765-766. PubMed ID: 28585064
    [No Abstract]   [Full Text] [Related]  

  • 55. In Vitro-in Vivo Correlation: An Unrealistic Problem.
    Hüttenrauch R; Speiser P
    Pharm Res; 1985 May; 2(3):97-107. PubMed ID: 24272686
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is the biopharmaceutical quality of extracts adequate for clinical pharmacology?
    Loew D
    Int J Clin Pharmacol Ther; 1997 Jul; 35(7):302-6. PubMed ID: 9247844
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Approaching the problem of bioequivalence of herbal medicinal products.
    Loew D; Kaszkin M
    Phytother Res; 2002 Dec; 16(8):705-11. PubMed ID: 12458470
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The importance of concomitant compounds in plant extracts].
    Eder M; Mehnert W
    Pharmazie; 1998 May; 53(5):285-93. PubMed ID: 9631497
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Characterization of plant extracts and registration requirements].
    Pifferi G
    Boll Chim Farm; 1990 Feb; 129(2):51-5. PubMed ID: 2275800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.